Skip to main content
Donate
Login
Celebrate IASLC's 50th Anniversary
Celebrate IASLC's 50th Anniversary
History
Support The Mission
Support The Mission
Partners for Thoracic Cancer Care
Legacy Society
IASLC Global Member Survey on Inclusivity
Learn About Us
Learn About Us
Strategic Plan
Board of Directors
Committees
Awards
Staff
Contact
Search
Donate
Login
Conferences & Webinars
Conferences & Webinars
Upcoming Conferences & Webinars
Past Conferences & Webinars
WCLC 2024
Research & Education
Research & Education
Scientific Projects
Scientific Projects
IASLC Staging Project: Lung Cancer, Thymic Tumors, and Mesothelioma
IASLC Global Survey on Biomarker Testing in Lung Cancer 2024 Update
IASLC Neoadjuvant Therapy in Lung Cancers Initiatives
IASLC Atlas of Molecular Testing for Targeted Therapy in Lung Cancer
ELIC
Past IASLC Scientific Projects
Lung Cancer 360
Journals
Journals
Journal of Thoracic Oncology
JTO Clinical and Research Reports (JTO CRR)
IASLC Reviewer Workshop
Early-Career Opportunities
Early-Career Opportunities
IASLC Academy
Publications, Resources & Guidelines
News
News
ILCN
Press Releases
Lung Cancer Considered Podcast
Membership
Membership
Become a Member
Renew Your Membership
IASLC Partnerships
Patient Advocacy
Patient Advocacy
STARS
Lung Cancer Awareness Month 2023 Highlights
Foundation
Foundation
Donor Recognition
Research Grant Program
Grant Recipient Spotlights
Research Grant Recipients
Search
Fulltext search
Fulltext search
Search
Displaying 1945 - 1956 items out of 1999 results
ILCN article
Concurrent IO with Chemoradiotherapy: Insights from PACIFIC-2
ILCN article
Big Tobacco Targets Medical Education
Webinar
Advancing Trustworthy Artificial Intelligence for Cancer Research
Podcast
Lung Cancer Considered in Spanish: Neoadjuvant Therapies In NSCLC
Podcast
WCLC 2024 Preview
Press release
International Lung Cancer Experts Seek Public Comments on Updated Molecular Testing Guideline to Improve Patient Selection and Targeted Therapies
Podcast
IASLC 50th Anniversary: The First Decade
Podcast
Lung Cancer Considered: in Mandarin
Podcast
FDA Approval: MARIPOSA, First-Line Amivantamab plus Lazertinib for EGFR NSCLC
ILCN article
Celebrate 5 Decades of the World Conference on Lung Cancer in San Diego’s Historic Gaslamp Quarter
ILCN article
2024 IASLC Academy to Once Again Compete in Amazing Case Race
ILCN article
Get Moving and Win During the 2024 Wellness Challenge
Pagination
First
First page
‹
Previous page
…
159
160
161
162
163
164
165
166
167
›
Next page
Last
Last page